[In vitro specific binding of Shiga toxin 1 and 2 by TAK-751S (Gb3 analog)].
TAK-751S is a synthetic trisaccharide coupled to Chromosorb P using a spacer sequence of 8-methoxycarboyloctyl (MCO). Its chemical structure is similar to a human receptor (Gb3) of Stx produced by enterohemorrhagic Escherichia coli (EHEC). In vitro efficacy of TAK-715S was studied by using ACHN cultured cell assay, which is sensitive and specific for measuring low level of Stx. Under various conditions, TAK-715S was mixed with purified Stx1 and Stx2, and residual free toxins in the solution were measured by using ACHN cells. TAK-715S was demonstrated to bind specifically to Stx1 and Stx2 under the condition similar to a human intestine while Chromsorb P did not bind to any Stx. The binding activity was stable in the presence of various processed foods, fresh vegetables and fruits. Antibiotics such as fosfomycin, kanamycin and norfloxacin did not disturb its binding capability. Minimum inhibitory concentrations of these antibiotics against Staphylococcus aureus FDA209P or E. coli NIHJ JC-2 neither changed after incubating with TAK-751S for 60 min at 37 degrees C. These results suggest that TAK-751S can be given orally with various foods and antibiotics for the elimination of Stx1 and Stx2 in the gut of patients with EHEC infections.
Takeda
T
T
TAKEDA Chemical Industries, Ltd., Pharmacology Laboratories, Pharmaceutical Research Division.
Yoshino
K
K
Adachi
E
E
Yamagata
K
K
Uchida
H
H
Okonogi
K
K
Iizawa
Y
Y
D000327:Adsorption; D001427:Bacterial Toxins; D007692:Diatomaceous Earth; D004768:Enterotoxins; D019453:Escherichia coli O157; D006801:Humans; D022603:Shiga Toxins; D014281:Trihexosylceramides; D014312:Trisaccharides
D001427:Bacterial Toxins; D004768:Enterotoxins; D022603:Shiga Toxins; D014281:Trihexosylceramides; D014312:Trisaccharides; D007692:Diatomaceous Earth; C018549:globotriaosylceramide